By understanding the science behind reduced absorption, you can partner with your healthcare team to implement targeted monitoring and intervention strategies
Promising Progress in the Obesity & Type 2 Diabetes Space Kaiera and Hengrui have reported positive Phase 3 results for their investigational oral GLP-1 therapy, marking another significant step forward in the evolving landscape of metabolic disease treatment
Its an ideal tool for the metabolically inflexible patient and is a driver for increasing insulin sensitivity which has profound health benefits such as reducing the risk of developing diabetes
By promoting more natural GH release, Ipamorelin can lead to improved sleep patterns and deeper, more restorative sleep, which is itself crucial for metabolic health and weight management
It helps your body do what it already knows how to do, just more effectively
Helps improve sleep patterns, mood and depression